Here is how to incorporate Pantone's Colour of the Year into your wardrobe and make-up. Read more at straitstimes.com.

COPENHAGEN, Jan 15 (Reuters) - Finland's Nokia (NOKIA.HE), opens new tab said on Wednesday it had signed a multi-year patent license agreement with Samsung (005930.KS), opens new tab, for the use ...

Jan 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to ...

v. Samsung Electronics Co., Ltd. affirming a final written decision by the Patent Trial and Appeal Board (PTAB) that invalidated Lynk Lab’s patent claims to alternating current driven LED lights ...

Pfizer saved $4 billion, plans $1.5 billion more in margin improvements, and issued $7 billion in dividends in nine months. Acquisitions are projected to offset $17 billion-18 billion in revenue ...

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said ...

Notably, Cantor Fitzgerald has experienced both sides of the patent system, defending its ownership of its innovations while also challenging others. A business leader like Lutnick, who has ample ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Nike is reportedly set to launch a Dunk Low "Patent Leather" sneakers pack in 2025. With this, the global footwear brand continues to reimagine its beloved Dunk Low silhouette. As per reports, the ...

But what are you using to stroll the city streets or pack for a luxury weekend holiday? Travel in elegance with a leather backpack, a choice that combines durability, versatility, and, most important ...

Those who received GLP-1s experienced decreased absolute and relative weight loss vs. placebo across 26 randomized studies. Retatrutide conferred the greatest weight reduction among all GLP-1s.

It addressed pivotal questions surrounding the scope, limitations and applicability of such claims, offering critical insights into patent law and its implications for the pharmaceutical industry.